Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
The Centers for Disease Control and Prevention July 28 reported 18,207 confirmed or suspected cases of cyclosporiasis across the U.S. from the current outbreak…
Headline
A Centers for Disease Control and Prevention report released July 16 found that wastewater surveillance failed to detect an internationally circulating measles…
Headline
Ryane Jackson, vice president of Community Health Network at Memorial Hermann Health System, explains how the system is creating seamless connections between…
Headline
The Department of Health and Human Services and the Centers for Medicare & Medicaid Services July 8 launched a voluntary pledge that hospitals can…
Perspective
The adoption of the Declaration of Independence on July 4, 1776, marked a pivotal turn for colonists, from a fight for rights as British subjects to the…
Chairperson's File
To improve the health of individuals and communities, hospitals and health systems provide holistic care to patients and work to address all factors that…